Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Lung Neoplasms 76Leukemia, Myeloid, Acute 70Prostatic Neoplasms 67Neoplasm Metastasis 56Carcinoma, Non-Small-Cell Lung 56Breast Neoplasms 45Multiple Myeloma 44Colorectal Neoplasms 40Pancreatic Neoplasms 36Myelodysplastic Syndromes 35Carcinoma, Renal Cell 33Ovarian Neoplasms 31Leukemia, Lymphocytic, Chronic, B-Cell 30Melanoma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Glioblastoma 27Triple Negative Breast Neoplasms 26Lymphoma, Large B-Cell, Diffuse 26Urinary Bladder Neoplasms 24Lymphoma 23Burkitt Lymphoma 22Squamous Cell Carcinoma of Head and Neck 21Glioma 20Fallopian Tube Neoplasms 20Carcinoma, Hepatocellular 18Mouth Neoplasms 17Leukemia, Biphenotypic, Acute 17Brain Neoplasms 17Sarcoma 16Oropharyngeal Neoplasms 16

Interventions

Photochemotherapy 3Metformin 3Pioglitazone 2Biopsy 2Aminolevulinic Acid 2Sulindac 1Specimen Handling 1Rosiglitazone 1Photosensitizing Agents 1Nivolumab 1Melatonin 1Gene Expression Profiling 1Fluorouracil 1Dihematoporphyrin Ether 1Dapsone 1Celecoxib 1Aspirin 1Acyclovir 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Leukoplakia, Oral × Specimen Handling × Clear all
NCT05237960 2026-04-20

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

University of Arizona

Phase 2 Active not recruiting
34 enrolled
Head & Neck

Erythroplasia, Leukoplakia, Oral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡